I.M.D. International Medical Devices S.P.A.

I.M.D. International Medical Devices S.P.A.

MMIL:IMD
1.21
EUR
-0.01
(-0.82%)
24.42MMarket Cap
Mar 03Next Earn
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.66
2.38
2.21
2.28
1.99
- -
Basic EPS, GAAP
0.23
0.17
0.13
0.13
0.08
- -
Free Cash Flow per Basic Share
0.18
-0.3
-0.17
0.43
0.1
- -
Dividend per Share
- -
0.01
- -
0.06
0.1
- -
Book Value per Share
0.63
0.8
1.24
1.35
1.33
1.33
Tangible Book Value per Share
0.6
0.78
1.17
1.27
1.26
1.26
Basic Weighted Avg Shares
18
18
17
17
17
17
Sales/Revenue/Turnover
47
42
38
39
35
- -
Operating Margin (%)
15.29
12.99
10.37
9
5.96
- -
Depreciation Expense
- -
- -
1
1
1
- -
Net Income, GAAP
4
3
2
2
1
- -
Effective Tax Rate (%)
26.82
34.03
31.31
31.36
25.65
- -
Profit Margin (%)
8.78
6.98
5.79
5.66
4.05
- -
Working Capital
13
17
22
23
22
22
LT Debt
- -
1
- -
- -
- -
- -
Total Equity
12
15
23
23
23
23
Return on Invested Capital (%)
- -
17.08
11.22
8.41
5.08
- -
Return on Capital (%)
- -
14.14
9.63
9.34
6.04
- -
Return on Common Equity (%)
- -
23.59
12.52
9.94
6.04
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
17
17
17
Market Capitalization
24
24
24

Working Capital

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
33
31
31
Cash, Cash Equivalents & STI
8
6
8
Accounts Receivable, Net
8
7
7
Inventories
14
15
12
Total Current Liabilities
10
9
8
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-1.44%
Free Cash Flow
- -
- -
-76.6%
Net Income, GAAP
- -
- -
-37.33%
Sales/Revenue/Turnover
- -
- -
-12.45%
Total Cash Common Dividend
- -
- -
54.07%

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
38
2024
- -
- -
39
2025
- -
- -
35

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.13
2024
- -
- -
0.13
2025
- -
- -
0.08

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
0.06
2025
- -
- -
0.1

Company Description

CEO
Aniello Aliberti
Full Time Employees
111
Sector
Health technology
Industry
Medical specialties
Address
Grassobbio Italy
IPO Date
Jul 7, 2023
Business
I.M.D. International Medical Devices S.p.A. is an Italy-based medical technology company that designs, develops, manufactures, and commercializes diagnostic imaging systems and high-frequency X-ray components for medical, surgical, and veterinary healthcare applications. Founded in 1974 and headquartered in Grassobbio, Italy, the company operates across two primary business divisions—Diagnostic Imaging Systems and X-Ray Components—supported by operating subsidiaries including Intermedical S.r.l. and IMD Generators S.r.l. The company's product and service portfolio encompasses: mobile surgical C-arm systems configured for orthopedic, vascular, interventional radiology, cardiological, and urological surgical procedures; motorized and manual mobile X-ray units for bedside hospital diagnostics; fixed digital radiography (DR) rooms, ceiling-suspended radiographic suites, and floor-mounted bucky systems; remote-controlled tilting fluoroscopy and general radiography tables; digital mammography systems and 3D breast tomosynthesis units; dual-energy X-ray absorptiometry (DEXA) bone densitometers; dental panoramic X-ray units; compact high-frequency monobloc X-ray generators; stationary high-voltage X-ray generators; X-ray tube housing assemblies, collimation units, and control consoles; proprietary digital image acquisition, enhancement, and archiving software; and contract OEM/ODM engineering, system integration, technical maintenance, spare parts distribution, regulatory support, and clinical operator training services. I.M.D. International Medical Devices S.p.A. serves public and private hospital networks, outpatient diagnostic centers, surgical clinics, private healthcare practices, veterinary institutions, and third-party medical device manufacturers across more than 100 countries throughout Europe, North America, Latin America, the Asia-Pacific region, the Middle East, and Africa. In recent developments, the company completed its initial public offering on the Euronext Growth Milan market to fund research and development initiatives, expand manufacturing capabilities, and accelerate international commercial distribution. The company has expanded its manufacturing footprint in Northern Italy, launched next-generation flat panel detector (FPD) mobile C-arm systems featuring integrated low-dose radiation management and artificial intelligence-assisted image reconstruction tools, formed new commercial distribution partnerships across North American and Asian healthcare markets, and implemented strategic supply chain integration measures to enhance component production efficiency and shorten lead times.